Literature DB >> 10771929

In vitro antibiotic sensitivity pattern of common bacterial isolates from cases of acute bacterial meningitis with special reference to ceftriaxone.

B N Rao1, I M Kashbur, N M Shembesh, S M el Bargathy.   

Abstract

Ceftriaxone (RO 13-9904) has only recently been introduced in Benghazi and many parts of the word. We determined its in-vitro antibacterial activity against the primary aetiological agents of childhood meningitis in Benghazi, that included eighteen (23.3%) strains of H. influenzae, 17 (22.1%) of Str. pneumoniae and 1 (1.3%) of N. meningitidis isolated from 77 cases of acute purulent meningitis above the age of neonatal period. All strains of H. influenzae. Str. pneumoniae and N. meningitidis were sensitive to ceftriaxone and showed wide zones of inhibition by the disc diffusion technique of Kirby-Bauer. Ampicillin and chloramphenicol resistance was observed for H. influenzae (23% and 11% respectively), and Str. pneumoniae (12% and 0% respectively), in addition, 18% of strains of Str. pneumoniae showed resistance to penicillin. The broad spectrum activity of ceftriaxone has been confirmed for our locality and this finding, together with its exceptionally long half-life, excellent penetration into the C.S.F. and ease of administration (single daily dose) warrants it as the drug of choice in empherical treatment of cases of acute bacterial meningitis in children in Benghazi and in cases where resistance to ampicillin and chloramphenicol are found on subsequent testing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10771929     DOI: 10.1007/bf02725510

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  26 in total

1.  Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing.

Authors:  P M Mendelman; D O Chaffin; C Clausen; T L Stull; C Needham; J D Williams; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Penicillin-insensitive Neisseria meningitidis.

Authors:  M S Sprott; A M Kearns; J M Field
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

3.  Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.

Authors:  R W Steele; L B Eyre; R W Bradsher; R E Weinfeld; I H Patel; J Spicehandler
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  Comparison of ceftriaxone with standard therapy for bacterial meningitis.

Authors:  R W Steele; R W Bradsher
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

5.  Antibiotic therapy of bacterial meningitis: lessons we've learned.

Authors:  M A Sande
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

6.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Statewide survey of the antimicrobial susceptibilities of Haemophilus influenzae producing invasive disease in Tennessee.

Authors:  T L Gustafson; R A Kelley; R H Hutcheson; W Schaffner; S H Sell
Journal:  Pediatr Infect Dis       Date:  1983 Mar-Apr

8.  Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver.

Authors:  G R Istre; J T Humphreys; K D Albrecht; C Thornsberry; J M Swenson; R S Hopkins
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

9.  Multiply resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study.

Authors:  J Campos; S García-Tornel; J M Gairí; I Fábregues
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

Review 10.  Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects.

Authors:  J Ward
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  1 in total

Review 1.  Antimicrobial resistance in Libya: 1970-2011.

Authors:  Khalifa Sifaw Ghenghesh; Amal Rahouma; Khaled Tawil; Abdulaziz Zorgani; Ezzedin Franka
Journal:  Libyan J Med       Date:  2013-03-27       Impact factor: 1.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.